Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82

The purpose of this study was to determine the clinical feasibility of diagnosing significant coronary artery disease by positron imaging of myocardial perfusion without a cyclotron, using generator-produced rubidium-82 (82Rb). Fifty patients underwent positron emission tomography of the entire heart using a multislice positron camera and intravenous 82Rb or nitrogen-13 ammonia (13NH3) before and after intravenous dipyridamole combined with handgrip stress. Images were read by two observers blinded as to clinical or arteriographic data. Automated quantitative coronary arteriography was obtained for the arteriographic determination of coronary flow reserve, previously demonstrated to be a single integrated measure of stenosis severity accounting for all its geometric dimensions of length, absolute diameter, percent narrowing and asymmetry by quantitative analysis of cine films. Significant coronary artery disease was defined as an arteriographically determined coronary flow reserve of less than 3.0 based on all stenosis dimensions. Any single geometric measure of stenosis severity alone was an inadequate reference standard for comparison with perfusion images. Sensitivity of identifying patients with coronary artery disease having an arteriographically determined coronary flow reserve of less than 3.0 was 95% by positron imaging with a specificity of 100%. The single case that was missed, studied with 13NH3, had a 43% diameter narrowing of a small ramus intermedius off the left coronary artery with no significant narrowing of the major coronary arteries. Positron emission tomography of myocardial perfusion before and after intravenous dipyridamole combined with handgrip stress utilizing generator-produced 82Rb provides sensitive and specific diagnosis of reduced coronary flow reserve due to coronary artery disease in humans.

This article has been cited by other articles:

				M. F. Di Carli and V. L. Murthy Cardiac PET/CT for the Evaluation of Known or Suspected Coronary Artery Disease RadioGraphics, September 1, 2011; 31(5): 1239 - 1254. [Abstract] [Full Text] [PDF]

				K. L. Gould Does Coronary Flow Trump Coronary Anatomy? J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 1009 - 1023. [Abstract] [Full Text] [PDF]

				G. El Fakhri, A. Kardan, A. Sitek, S. Dorbala, N. Abi-Hatem, Y. Lahoud, A. Fischman, M. Coughlan, T. Yasuda, and M. F. Di Carli Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET J. Nucl. Med., July 1, 2009; 50(7): 1062 - 1071. [Abstract] [Full Text] [PDF]

				D. S. Berman and J. K. Min Can Coronary Computed Tomographic Angiography Trigger Coronary Revascularization?: Questioning the Appropriateness of the Question J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 558 - 560. [Full Text] [PDF]

				K. L. Gould Coronary flow reserve and pharmacologic stress perfusion imaging beginnings and evolution. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 664 - 669. [Full Text] [PDF]

				M. R. Vesely and V. Dilsizian Nuclear Cardiac Stress Testing in the Era of Molecular Medicine J. Nucl. Med., March 1, 2008; 49(3): 399 - 413. [Abstract] [Full Text] [PDF]

				J Knuuti and F M Bengel Positron emission tomography and molecular imaging Heart, March 1, 2008; 94(3): 360 - 367. [Abstract] [Full Text] [PDF]

				M. F. Di Carli, S. Dorbala, J. Meserve, G. El Fakhri, A. Sitek, and S. C. Moore Clinical Myocardial Perfusion PET/CT J. Nucl. Med., May 1, 2007; 48(5): 783 - 793. [Abstract] [Full Text] [PDF]

				M. F. Di Carli and R. Hachamovitch New Technology for Noninvasive Evaluation of Coronary Artery Disease Circulation, March 20, 2007; 115(11): 1464 - 1480. [Full Text] [PDF]

				U. K. Sampson, S. Dorbala, A. Limaye, R. Kwong, and M. F. Di Carli Diagnostic Accuracy of Rubidium-82 Myocardial Perfusion Imaging With Hybrid Positron Emission Tomography/Computed Tomography in the Detection of Coronary Artery Disease J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1052 - 1058. [Abstract] [Full Text] [PDF]

				K. Yoshinaga, B. J.W. Chow, K. Williams, L. Chen, R. A. deKemp, L. Garrard, A. Lok-Tin Szeto, M. Aung, R. A. Davies, T. D. Ruddy, et al. What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography? J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1029 - 1039. [Abstract] [Full Text] [PDF]

				N. P. Johnson and K. L. Gould Clinical Evaluation of a New Concept: Resting Myocardial Perfusion Heterogeneity Quantified by Markovian Analysis of PET Identifies Coronary Microvascular Dysfunction and Early Atherosclerosis in 1,034 Subjects J. Nucl. Med., September 1, 2005; 46(9): 1427 - 1437. [Abstract] [Full Text] [PDF]

				G. El Fakhri, A. Sitek, B. Guerin, M. F. Kijewski, M. F. Di Carli, and S. C. Moore Quantitative Dynamic Cardiac 82Rb PET Using Generalized Factor and Compartment Analyses J. Nucl. Med., August 1, 2005; 46(8): 1264 - 1271. [Abstract] [Full Text] [PDF]

				J. I. E. Hoffman Do we have agold standard yet? J. Am. Coll. Cardiol., February 18, 2004; 43(4): 662 - 664. [Full Text] [PDF]

				F. Pizzuto, P. Voci, E. Mariano, P. Emilio Puddu, G. Sardella, and A. Nigri Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting J. Am. Coll. Cardiol., July 1, 2001; 38(1): 155 - 162. [Abstract] [Full Text] [PDF]

				S. Sdringola, D. Patel, and K. L. Gould High Prevalence of Myocardial Perfusion Abnormalities on Positron Emission Tomography in Asymptomatic Persons With a Parent or Sibling With Coronary Artery Disease Circulation, January 30, 2001; 103(4): 496 - 501. [Abstract] [Full Text] [PDF]

				O. O. Akinboboye, O. Idris, R.-L. Chou, R. R. Sciacca, P. J. Cannon, and S. R. Bergmann Absolute quantitation of coronary steal induced by intravenous dipyridamole J. Am. Coll. Cardiol., January 1, 2001; 37(1): 109 - 116. [Abstract] [Full Text] [PDF]

				T. Hozumi, K. Yoshida, T. Akasaka, Y. Asami, Y. Ogata, T. Takagi, S. Kaji, T. Kawamoto, Y. Ueda, and S. Morioka Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: Comparison with invasive technique J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1251 - 1259. [Abstract] [Full Text] [PDF]

				T. Hozumi, K. Yoshida, Y. Ogata, T. Akasaka, Y. Asami, T. Takagi, and S. Morioka Noninvasive Assessment of Significant Left Anterior Descending Coronary Artery Stenosis by Coronary Flow Velocity Reserve With Transthoracic Color Doppler Echocardiography Circulation, April 28, 1998; 97(16): 1557 - 1562. [Abstract] [Full Text] [PDF]

				D. D. Miller, T. J. Donohue, T. L. Wolford, M. J. Kern, S. R. Bergmann, C. M. Mechem, and J. J. Hartman Assessment of Blood Flow Distal to Coronary Artery Stenoses: Correlations Between Myocardial Positron Emission Tomography and Poststenotic Intracoronary Doppler Flow Reserve Circulation, November 15, 1996; 94(10): 2447 - 2454. [Abstract] [Full Text]

				K. L. Gould, D. Ornish, L. Scherwitz, S. Brown, R. P. Edens, M. J. Hess, N. Mullani, L. Bolomey, F. Dobbs, W. T. Armstrong, et al. Changes in Myocardial Perfusion Abnormalities by Positron Emission Tomography After Long-term, Intense Risk Factor Modification JAMA, September 20, 1995; 274(11): 894 - 901. [Abstract] [PDF]

				R. F. Redberg, Y. Sobol, T. M. Chou, M. Malloy, S. Kumar, E. Botvinick, and J. Kane Adenosine-Induced Coronary Vasodilatation During Transesophageal Doppler Echocardiography : Rapid and Safe Measurement of Coronary Flow Reserve Ratio Can Predict Significant Left Anterior Descending Coronary Stenosis Circulation, July 15, 1995; 92(2): 190 - 196. [Abstract] [Full Text]

				M. Di Carli, J. Czernin, C. K. Hoh, V. H. Gerbaudo, R. C. Brunken, S.-C. Huang, M. E. Phelps, and H. R. Schelbert Relation Among Stenosis Severity, Myocardial Blood Flow, and Flow Reserve in Patients With Coronary Artery Disease Circulation, April 1, 1995; 91(7): 1944 - 1951. [Abstract] [Full Text]

				G. A. Beller Pharmacologic Stress Imaging JAMA, February 6, 1991; 265(5): 633 - 638. [Abstract] [PDF]

				The Workshop Panel National Cancer Institute Workshop Statement: Advances in Clinical Imaging Using Positron Emission Tomography, September 14-16, 1988 Arch Intern Med, April 1, 1990; 150(4): 735 - 739. [Abstract] [PDF]

				H. N. Wagner Jr Nuclear Medicine JAMA, May 19, 1989; 261(19): 2860 - 2862. [Abstract] [PDF]

				Council on Scientific Affairs Report of the Positr, G. M. Bohigian, E. H. Estes Jr, I. R. Friedlander, W. R. Kennedy, J. H. Moxley III, P. Numann, P. S. Salva, W. C. Scott, J. H. Skom, et al. Application of Positron Emission Tomography in the Heart JAMA, April 22, 1988; 259(16): 2438 - 2445. [Abstract] [PDF]

				R. DETRANO and V. FROELICHER A Logical Approach to Screening for Coronary Artery Disease Ann Intern Med, June 1, 1987; 106(6): 846 - 852. [Abstract] [PDF]